BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 78369)

  • 1. Anaphylactic reaction to intralesional B.C.G.
    Proctor JW; Zidar B; Pomerantz M; Yamamura Y; Eng CP; Woodside D
    Lancet; 1978 Jul; 2(8081):162. PubMed ID: 78369
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy of melanoma with BCG: two fatalities following intralesional injection.
    McKhann CF; Hendrickson CG; Spitler LE; Gunnarsson A; Banerjee D; Nelson WR
    Cancer; 1975 Feb; 35(2):514-20. PubMed ID: 234291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulomatous hepatitis: a complication of B.C.G. immunotherapy.
    Hunt JS; Silverstein MJ; Sparks FC; Haskell CM; Pilch YH; Morton DL
    Lancet; 1973 Oct; 2(7833):820-1. PubMed ID: 4126618
    [No Abstract]   [Full Text] [Related]  

  • 4. Risks of BCG intralesional therapy: an experience with melanoma.
    Robinson JC
    J Surg Oncol; 1977; 9(6):587-93. PubMed ID: 145518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epilesional scarification. Preliminary report of a new approach to local immunotherapy with BCG.
    Richman SP; Mavligit GM; Wolk R; Gutterman JU; Hersh EM
    JAMA; 1975 Dec; 234(12):1233-5. PubMed ID: 1242748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe complications of intralesional BCG therapy in an unsensitized patient. Case report and clinical implications.
    Felix EL; Jessup JM; Cohen MH
    Arch Surg; 1978 Jul; 113(7):893-6. PubMed ID: 678104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCG and cancer.
    Bast RC; Zbar B; Borsos T; Rapp HJ
    N Engl J Med; 1974 Jun; 290(26):1458-69. PubMed ID: 4598691
    [No Abstract]   [Full Text] [Related]  

  • 8. BCG immunotherapy of malignant melanoma: summary of a seven-year experience.
    Morton DL; Eilber FR; Holmes EC; Hunt JS; Ketcham AS; Silverstein MJ; Sparks FC
    Ann Surg; 1974 Oct; 180(4):635-43. PubMed ID: 4412271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distant cutaneous granulomas after bacille Calmette-Guérin immunotherapy for malignant melanoma: case for direct infection.
    Moff SL; Corey GR; Gottfredsson M
    Clin Infect Dis; 1999 Dec; 29(6):1569-70. PubMed ID: 10585816
    [No Abstract]   [Full Text] [Related]  

  • 10. Regression of pulmonary metastatic disease associated with intralesional BCG therapy of intracutaneous melanoma metastases.
    Mastrangelo MJ; Bellet RE; Berkelhammer J; Clark WH
    Cancer; 1975 Oct; 36(4):1305-8. PubMed ID: 1175129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Malignant melanoma arising de novo within a B.C.G. scarification site.
    Lokich JJ
    Lancet; 1975 Feb; 1(7902):331-2. PubMed ID: 46469
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary inoculation tuberculosis after immunotherapy for malignant melanoma with BCG vaccine.
    Caplan SE; Kauffman CL
    J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):783-5. PubMed ID: 8912582
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intralesion BCG vaccine therapy in cutaneous melanoma metastasis].
    Wolf M; Menzel W
    Dermatol Monatsschr; 1978 Sep; 164(9):671-2. PubMed ID: 710658
    [No Abstract]   [Full Text] [Related]  

  • 14. Granulomatous eruption after BCG vaccine immunotherapy for malignant melanoma.
    Shea CR; Imber MJ; Cropley TG; Cosimi AB; Sober AJ
    J Am Acad Dermatol; 1989 Nov; 21(5 Pt 2):1119-22. PubMed ID: 2681298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic granulomas and other hepatic lesions associated with BCG immunotherapy for cancer.
    Bodurtha A; Kim YH; Laucius JF; Donato RA; Mastrangelo MJ
    Am J Clin Pathol; 1974 Jun; 61(6):747-52. PubMed ID: 4598826
    [No Abstract]   [Full Text] [Related]  

  • 16. Intralesional BCG application in malignant melanoma.
    Sopková B; Kolár V
    Neoplasma; 1976; 23(4):421-6. PubMed ID: 794745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of immunotherapy in the treatment of malignant melanoma of the skin].
    Kristensen E
    Ugeskr Laeger; 1976 Feb; 138(8):468-73. PubMed ID: 1258215
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of malignant melanoma by intratumoral injection of BCG.
    Pinsky CM; Hirshaut Y; Oettgen HF
    Natl Cancer Inst Monogr; 1973 Dec; 39():225-8. PubMed ID: 4595322
    [No Abstract]   [Full Text] [Related]  

  • 19. Prospective comparison of intralesional and multipuncture BCG in recurrent intradermal melanoma.
    Nathanson L; Schoenfeld D; Regelson W; Colsky J; Mittelman A
    Cancer; 1979 May; 43(5):1630-5. PubMed ID: 376098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of melanoma with intralesional BCG.
    Bornstein RS; Mastrangelo MJ; Sulit H; Chee D; Yarbro JW; Prehn LM; Prehn RT
    Natl Cancer Inst Monogr; 1973 Dec; 39():213-20. PubMed ID: 4595320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.